Gastric Cancer Survival Without Chemotherapy
NCT05125614 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 342
Last updated 2021-11-30
Summary
This study is observational study to analyze the actual overall survival of the patients who did not receive adjuvant chemotherapy after curative gastrectomy for gastric cancer.
The investigators developed prediction model for the overall survival of these patients and validated.
Conditions
Interventions
- OTHER
-
No adjuvant chemotherapy
There is no intervention differences between 2 groups. We analyzed the data of the patients who did not receive adjuvant chemotherapy.
Sponsors & Collaborators
-
Saint Vincent's Hospital, Korea
lead OTHER
Principal Investigators
-
Ki Bum Park, M.D. · St Vincent's Hospital
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2021-06-01
- Completion
- 2021-07-01
Countries
- South Korea
Study Locations
More Related Trials
-
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
NCT01917552 ·Status: RECRUITING ·Phase: PHASE3
-
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
NCT00915382 ·Status: COMPLETED ·Phase: PHASE3
-
Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXP
NCT00976976 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer
NCT01946061 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
NCT00587145 ·Status: UNKNOWN ·Phase: PHASE2
-
Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage
NCT06194981 ·Status: RECRUITING
-
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
NCT01471470 ·Status: COMPLETED ·Phase: PHASE2
-
S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma
NCT02495493 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
NCT02114359 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer
NCT01756183 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
NCT03978481 ·Status: COMPLETED
-
Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
NCT00515190 ·Status: UNKNOWN ·Phase: PHASE2
-
Pharmacogenomic Study (Adjuvant Chemotherapy)
NCT01470404 ·Status: COMPLETED
-
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC)
NCT03941561 ·Status: RECRUITING ·Phase: PHASE3
-
Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer
NCT03485105 ·Status: UNKNOWN
-
Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer
NCT06525714 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)
NCT03403296 ·Status: COMPLETED
-
S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
NCT01671449 ·Status: COMPLETED ·Phase: PHASE3
-
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
NCT00510107 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer
NCT00512681 ·Status: COMPLETED ·Phase: PHASE2
-
Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer
NCT03042169 ·Status: TERMINATED ·Phase: PHASE3
-
A Safety and Efficacy Study in Patients With Gastric Cancer
NCT00400179 ·Status: COMPLETED ·Phase: PHASE3
-
Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH
NCT01935778 ·Status: RECRUITING ·Phase: PHASE3
-
Trial of Adjuvant Chemotherapy for Gastric Cancer
NCT00296335 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
NCT06277453 ·Status: ACTIVE_NOT_RECRUITING